Pioneers of blood and tissue microbiome exploration, we are leaders in low bacterial biomass sample analysis

ABOUT VAIOMER
V de Voimer

Microbiome analysis for convincing data

Our contamination aware approach is crucial

By carefully controlling for contamination at every step of microbiome analysis, we provide reliable data that reflect the actual bacterial load of tissues rather than contaminants.

Mission

Vaiomer microbiome analysis stimulates the discovery

of new disease mechanisms, new biomarkers to contribute to personalized medecine, new pathways to identify novel therapeutic targets.

Microbiome analysis applications

Blood and tissue microbiota in health and diseases

Cardio - metabolic diseases

Liver diseases

Gastrointestinal disorders

Cancer

Neurodegenerative and mental disorders

COVID, HIV & infectious diseases

COVID, HIV & infectious diseases

Autoimmune and inflammatory diseases

Nutrition

Kidney diseases

Microbiome in early life

Vaiomer microbiome expertise

Exploring the circulating and tissue microbiomes

Beyond the human gut microbiome

The microbiota is not only located in the gut. It expands to every part of the body, ranging from very high to very low bacterial biomass. Learn more by travelling through our microbiome atlas.

Vaiomer tailor - made metagenomics

Challenging low bacterial biomass samples are now accessible thanks to our specifically optimized and contamination-aware metagenomic workflow. Discover our microbiome analysis services.

INNOVATORS’ EXPERIENCE

The early explorers of tissue microbiomes

Dowload our white paper

 

Learn about the gut, blood and tissue microbiota, the link between gut dysbiosis and tissue inflammation, and discover how these microbiota positively or negatively influence our physiology and can cause disease

 

News and views

VAIOMER Experts’ Highlights

Vaiomer is participating in the next Neurex meeting on advanced concepts in neuroimmunology
Vaiomer is taking part in the next Neurex meeting on advanced concepts in neuroimmunology

Vaiomer is participating in the next Neurex meeting on advanced concepts in neuroimmunology

> Vaiomer is taking part in the meeting “Advanced Concepts In Neuroimmunology: From Environmental Stressors To Neurological Disorders” on November 24 in Strasbourg, FRANCE.
> Do not miss our talk on “Tissue microbiota analysis for pathogen identification and skin microbiome alteration assessment after tick bite” at 14:45.

Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum: Europe 2022
Vaiomer is happy to announce that we will be attending the Microbiome R&D and Business Collaboration Forum: Europe 2022

Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum: Europe 2022

> Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum on May 24 & 25, in The Hague, THE NETHERLANDS
> Come visit our booth and do not miss our talk “Bacterial translocation: a new perspective on the microbiota-gut-brain axis?”
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.

Vaiomer is taking part to the next Eurobiomed cluster thematic meeting on Oncology
Vaiomer will present at the next Eurobiomed cluster thematic meeting on May 12 about Oncology

Vaiomer is taking part to the next Eurobiomed cluster thematic meeting on Oncology

> Vaiomer will be participating to Oncology: Horizon 2030 Technologies and models to address tumor heterogeneity for better personalized medicine, on May 12 in Toulouse, FRANCE.
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.

FRANCE RELANCE